Cargando…

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model

Human embryonic stem cells (hESCs) can potentially differentiate into any cell type, including dopaminergic neurons to treat Parkinson's disease (PD), but hyperproliferation and tumor formation must be avoided. Accordingly, we use myocyte enhancer factor 2C (MEF2C) as a neurogenic and anti-apop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Eun-Gyung, Zaremba, Jeffrey D., McKercher, Scott R., Talantova, Maria, Tu, Shichun, Masliah, Eliezer, Chan, Shing Fai, Nakanishi, Nobuki, Terskikh, Alexey, Lipton, Stuart A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162026/ https://www.ncbi.nlm.nih.gov/pubmed/21901155 http://dx.doi.org/10.1371/journal.pone.0024027

Ejemplares similares

Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells
por: Chan, Shing Fai, et al.
Publicado: (2014)

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
por: Tu, Shichun, et al.
Publicado: (2017)

Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency
por: Nagar, Saumya, et al.
Publicado: (2017)

Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models
por: Lipton, Stuart A, et al.
Publicado: (2016)

S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease
por: Sunico, Carmen R, et al.
Publicado: (2013)

Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
por: Takahashi, Hiroto, et al.
Publicado: (2015)

Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
por: Takahashi, Hiroto, et al.
Publicado: (2016)

NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice
por: Hernandes, Marina S., et al.
Publicado: (2013)

Conditioned Medium Protects Dopaminergic Neurons in Parkinsonian Rats
por: Nakhaeifard, Malihe, et al.
Publicado: (2018)

Different Dopaminergic Dysfunctions Underlying Parkinsonian Akinesia and Tremor
por: Caligiore, Daniele, et al.
Publicado: (2019)

CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes
por: Zhang, Wenlong, et al.
Publicado: (2020)

The Estimated Impact of Drug Importation, Mandatory Mail Service, and Medicaid Fee Reduction on Community Pharmacies in Michigan
por: McKercher, Patrick L.
Publicado: (2006)

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
por: Lu, Xi, et al.
Publicado: (2014)

Mouse Embryonic Stem Cells Expressing GDNF Show Enhanced Dopaminergic Differentiation and Promote Behavioral Recovery After Grafting in Parkinsonian Rats
por: Lara-Rodarte, Rolando, et al.
Publicado: (2021)

Professional CUDA C programming
por: Cheng, John, et al.
Publicado: (2014)

Living on the edge
por: McKercher, Bob, et al.
Publicado: (2006)

The Over-Reaction to SARS and the Collapse of Asian Tourism
por: McKercher, Bob, et al.
Publicado: (2004)

Editorial: Special issue on CAUTHE 2021 conference
por: Scerri, Madalyn, et al.
Publicado: (2022)

Nrf2 and HSF-1 Pathway Activation via Hydroquinone-Based Proelectrophilic Small Molecules Is Regulated by Electrochemical Oxidation Potential
por: Satoh, Takumi, et al.
Publicado: (2015)

Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats
por: Taravini, Irene RE, et al.
Publicado: (2011)

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
por: Tain, Luke S, et al.
Publicado: (2009)

Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System
por: Leem, Eunju, et al.
Publicado: (2016)

Dopaminergic Modulation of Spectral and Spatial Characteristics of Parkinsonian Subthalamic Nucleus Beta Bursts
por: Sure, Matthias, et al.
Publicado: (2021)

NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
por: Ghatak, Swagata, et al.
Publicado: (2021)

Do destinations have multiple lifecycles?
por: McKercher, Bob, et al.
Publicado: (2021)

Does the environment matter in the ‘new normal’?
por: Mkono, Mucha, et al.
Publicado: (2022)

Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses
por: Yan, Junqiang, et al.
Publicado: (2011)

22(R)-hydroxycholesterol for dopaminergic neuronal specification of MSCs and amelioration of Parkinsonian symptoms in rats
por: Singh, Manisha, et al.
Publicado: (2021)

Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review
por: Bessell, Erica, et al.
Publicado: (2015)

Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice
por: Sgobio, Carmelo, et al.
Publicado: (2019)

Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes
por: Yang, Hao, et al.
Publicado: (2019)

The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats
por: da Costa, Roberta Oliveira, et al.
Publicado: (2017)

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
por: Morbelli, Silvia, et al.
Publicado: (2020)

DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms
por: Seo, Dong-Chan, et al.
Publicado: (2023)

Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
por: Clark, Joanne, et al.
Publicado: (2010)

Corrigendum to “The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats”
por: da Costa, Roberta Oliveira, et al.
Publicado: (2018)

Biochemical Changes Induced by Embryonic Substantia Nigra Transplanted to the Striatum of Parkinsonian Monkeys
por: Elsworth, J. D., et al.
Publicado: (1992)

GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
por: Chen, Cang, et al.
Publicado: (2018)

Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats
por: Lee, Tony Tung-Yin, et al.
Publicado: (2012)

Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson’s disease
por: Gao, Qing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8gcf48ci6c16m0ts9inctpjvus